Skip to content

UGT1A1 Gene Mutation Status (Tay-Sachs Variant)

Published: August 9, 2026Updated: August 16, 2026

This test checks for a specific genetic variation in the UGT1A1 gene, which may affect how your body processes certain medications or contribute to inherited conditions like Crigler-Najjar syndrome.

Quick summary

["This genetic test helps identify a rare variant linked to potential drug interactions or metabolic conditions."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
51951-2
Short code
UGT1A1 allele 1 Bld/T
Synonyms
UGT1A1 allele 1 Bld/T
Category
chemistry
Sample
whole-blood
Container
Lavender-top (EDTA)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
molgen
Specimen volume
3 mL
Stability
Room temperature: 4h, Refrigerated: 24h
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
4–24 hours
Order
routine

Why This Test Might Be Ordered

Your healthcare provider may recommend this test if you have a family history of conditions like Crigler-Najjar syndrome, severe jaundice in newborns, or if you’re considering medications that rely on UGT1A1 metabolism (e.g., certain chemotherapy drugs). It’s also sometimes used in prenatal screening for genetic risks.

What to Expect Before the Test

No special preparation is needed. A small blood sample will be taken, similar to a routine blood draw. Results are typically available within 1–2 weeks.

What the Results Mean

Results will indicate whether you carry the UGT1A1 allele variant associated with reduced enzyme function. This may influence medication choices or monitoring for metabolic issues.

Common Conditions Linked to This Variant

The variant may increase risk for conditions like severe jaundice in newborns (Crigler-Najjar syndrome) or altered drug metabolism, potentially affecting how your body processes medications like irinotecan.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

This test helps identify a genetic mutation that can alter drug metabolism, potentially causing severe reactions to certain medications. For example, the variant may lead to higher drug levels in your blood, increasing toxicity risks. It’s particularly relevant for patients with a family history of inherited metabolic disorders or those prescribed drugs metabolized by this enzyme.

Short name

UGT1A1 Mutation Screening

Frequently asked questions

What does a positive result mean for my health?
A positive result indicates you carry the UGT1A1 allele variant. This may require your doctor to adjust medications, especially those metabolized by this enzyme, to avoid side effects or toxicity. Follow-up with your healthcare provider to discuss personalized care plans.
Will this test affect my ability to get pregnant?
This genetic test does not directly impact fertility, but if you have a family history of Crigler-Najjar syndrome or related conditions, prenatal genetic counseling may be recommended to assess risks for your future children.
How long will I need to wait for results?
Results typically take 1–2 weeks after the blood sample is processed. Your healthcare provider will contact you once results are available, either through a phone call or secure message.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy